Disease Treat

Know About Ulcers Blog

חשיבות הניטור ומטרות הטיפול במחלות מעי דלקתיות

Inflammatory bowel diseases:
Importance of surveillance and their treatment objectives Inflammatory bowel diseases are chronic diseases,
that cause damage to the digestive system, and which are associated with symptoms that affect
the patients’ quality of life. In order for the treatment of these diseases to be effective,
and in order to achieve complete remission, it is necessary to treat and monitor
inflammatory bowel diseases over time. On this and more, in the following video. It was previously thought that inflammatory bowel diseases
consist of one Crohn’s disease and one ulcerative colitis disease. Today we have a slightly different understanding of things. We speak of several Crohn’s diseases
and several ulcerative colitis diseases. Consequently, we must practice tailored medicine. Inflammatory bowel diseases are autoimmune diseases,
in which the body attacks itself. The reasons for this are not fully known,
we used to think there is a genetic component. Today we speak of the environmental component
as the dominant one. Change in nutrition, industrialized food, smoking,
excessive hygiene and the type of water. All these have probably caused a change in the fabric
of bacteria and an autoimmune process, which we see in both these diseases. It was previously thought that Crohn’s diseases
are characterized by diarrhea, abdominal pains, weight loss, which actually testify
to the inflammatory process itself. Today we understand that there is no connection
between how the patient feels and the degree of the inflammation, Therefore,
today we speak of objective monitoring of the disease by a multidisciplinary team. What does this even mean? A multidisciplinary team watches
and monitors the patient at regular intervals, not only the symptoms,
but the degree of inflammation in the stool by collecting stool for calprotectin,
by repeating blood tests, by testing CRP,
hemoglobin testing, endoscopic tests: colonoscopy
and gastroscopy, and an MR enterography,
which is an MRI of the small intestine. Let’s start to understand,
who even needs treatment. A third of our patients don’t need treatment at all. They do need objective surveillance,
but do not necessarily need treatment. For those who need treatment, those patients
with moderate to severe inflammatory bowel diseases, we have to provide tailored medicine
and a medication that will suit their disease specifically. What does it mean?
It means that when treatment is started, we will conduct objective-close monitoring
that includes stool calprotectin tests, blood tests and imaging tests. If we ensure that all the parameters, both the subjective
and the objective ones are under control, we will achieve long-term remission
and without complications. In summary, inflammatory bowel diseases consist
of several Crohn’s diseases and several ulcerative colitis diseases. Each patient requires treatment depending
on his type of disease. In the course of treatment, it is important to conduct close
and objective monitoring of parameters, that will testify to the control of the inflammation.
If the inflammation is under control, we will reduce hospitalizations, reduce unnecessary use of steroids
and reduce long-term complications.

Leave a Reply

Your email address will not be published. Required fields are marked *